Oklo (NYSE: OKLO) has seen its updated fair value estimate fall to US$78.69 from US$88.63, marking roughly an 11% decline in the latest model refresh.
The revision arrives as analysts grapple with a wide spread in price targets, reflecting deep disagreement over how the company’s first-of-a-kind nuclear projects will ultimately perform.
Texas Capital continues to hold Oklo as its top pick within the nuclear group, maintaining a US$89 price target and citing the company’s balance sheet strength and vertical integration efforts.
Barclays holds an Overweight rating with a US$76 price target, pointing specifically to Oklo’s progress on fuel optionality through Department of Energy plutonium and Centrus agreements as commercialization draws closer.
Piper Sandler initiated coverage with an Overweight rating and a US$55 price target, citing bipartisan policy support for nuclear energy and surging hyperscaler demand for firm, carbon-free power.
On the bearish side, Truist assigned a Hold rating and a US$51 price target, framing the central debate around first-of-a-kind economics and the path toward lower-cost repeat deployments.
Guggenheim took a Neutral stance with no price target, highlighting the capital-intensive nature of Oklo’s business model and suggesting free cash flow could remain elusive while the company continues expanding its asset base.
The updated model also reflects changes across several key financial assumptions, with revenue growth now projected at approximately 320.17%, compared with 323.99% previously.
Net profit margin has been revised slightly upward to approximately 15.01% from 14.87%, while the future price-to-earnings multiple has been cut to 1,634.92x from 2,046.74x, both figures reflecting the speculative nature of early-stage nuclear deployment.
The discount rate used in the model has also been adjusted upward to 7.24% from 7.11%, adding modest additional pressure to the fair value calculation.
Analysts and investors are watching several key execution risks closely, including potential project delays, uncertainty around HALEU and plutonium fuel sourcing, and the significant capital requirements tied to Oklo’s build-own-operate model.
Federal programs such as the Reactor Pilot Program and the Fuel Line Pilot Program remain central to the timing outlook for Oklo’s first reactors and fuel facilities, making policy developments a critical variable for the stock.
Oklo’s vertically integrated strategy, which spans power generation, fuel processing, and isotope production through ventures including the Advanced Fuel Center in Tennessee and Atomic Alchemy’s VIPR reactor, continues to define both its long-term upside and near-term complexity.
The stock was down 4.16% at the time of the latest analyst commentary, underscoring market sensitivity to shifting valuation assumptions and ongoing uncertainty around commercialization timelines.
